Dominant T- and B-cell epitopes in an autoantigen linked to Chagas' disease.

In Chagas' disease caused by Trypanosoma cruzi, a paradigm of autoimmune disease, both autoantibodies and autoreactive T cells have been described. We have identified a novel dominant autoantigen, named Cha, recognized by the majority of sera from T. cruzi-infected humans and mice. We noted significant homologies between amino acids 120-129 of Cha, where the B-cell epitope maps, and an expressed sequence tag from T. cruzi, and also between amino acids 254-273 of Cha and a repeated amino acid sequence from the shed acute-phase antigen (SAPA) of T. cruzi. Moreover, T. cruzi-infected mice contain autoreactive T cells that can cross-react with Cha and the SAPA homologous peptides. Transfer of T cells from infected mice triggered anti-Cha (120-129) Ab production in naive recipients. Interestingly, heart tissue sections from those adoptive transferred mice showed cardiac pathology similar to T. cruzi-infected mice. Our results demonstrate the presence of both T- and B-cell cross-reactive epitopes in the Cha antigen. This dual mimicry may lead to T/B cell cooperation and give rise to a pathological immunodominant response against Cha in T. cruzi infected animals.

[1]  C. Benoist,et al.  Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. , 1999, Science.

[2]  J. Hoebeke,et al.  Functionally active cardiac antibodies in chronic Chagas' disease are specifically blocked by Trypanosoma cruzi antigens , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  A. Steere,et al.  Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. , 1998, Science.

[4]  H Cantor,et al.  Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. , 1998, Science.

[5]  R. Tarleton,et al.  "Autoimmune rejection" of neonatal heart transplants in experimental Chagas disease is a parasite-specific response to infected host tissue. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[6]  F. Kierszenbaum.  Chronic chagasic tissue lesions in the absence of Trypanosoma cruzi: a proposed mechanism. , 1996, Parasitology today.

[7]  J. Kalil,et al.  Autoimmunity in chagas disease cardiomyopathy: Fulfilling the criteria at last? , 1996, Parasitology today.

[8]  R. Coffman,et al.  Cytokine and nitric oxide regulation of the immunosuppression in Trypanosoma cruzi infection. , 1995, Journal of immunology.

[9]  P. Chiale,et al.  Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1- adrenergic receptor , 1995, The Journal of experimental medicine.

[10]  J. Strominger,et al.  Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein , 1995, Cell.

[11]  J. McCarthy,et al.  Translational regulation of a recombinant operon containing human platelet-derived growth factor (PDGF)-encoding genes in Escherichia coli: genetic titration of the peptide chains of the heterodimer AB. , 1994, Gene.

[12]  E. Bonfá,et al.  Autoantibodies in Chagas' disease. An antibody cross-reactive with human and Trypanosoma cruzi ribosomal proteins. , 1993, Journal of immunology.

[13]  T. McCormick,et al.  Differential cardiac histopathology in inbred mouse strains chronically infected with Trypanosoma cruzi. , 1992, The Journal of parasitology.

[14]  V. Nussenzweig,et al.  Stage-specific expression and intracellular shedding of the cell surface trans-sialidase of Trypanosoma cruzi , 1992, Infection and immunity.

[15]  W. V. Van Voorhis,et al.  Molecular mimicry by Trypanosoma cruzi: the F1-160 epitope that mimics mammalian nerve can be mapped to a 12-amino acid peptide. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[16]  H. M. Geysen,et al.  Multi-pin peptide synthesis strategy for T cell determinant analysis. , 1990, Journal of immunological methods.

[17]  H. Eisen,et al.  Chagas disease: a model for the study of autoimmune diseases. , 1989, Parasitology today.

[18]  P. Gruss,et al.  Expression of synthetic genes encoding bovine and human basic fibroblast growth factors (bFGFs) in Escherichia coli. , 1989, Gene.

[19]  P. Carnegie,et al.  An Approach to Searching Protein Sequences for Superfamily Relationships or Chance Similarities Relevant to the Molecular Mimicry Hypothesis: Application to the Basic Proteins of Myelin , 1988, Journal of neurochemistry.

[20]  G. Schmuñis.  Autoimmunity in Chagas' disease , 1987 .

[21]  A. Alcina,et al.  Activation by synergism between endotoxin and lymphokines of the mouse macrophage cell line J774 against infection by Trypanosoma cruzi , 1987, Parasite immunology.

[22]  T. Jessell,et al.  A monoclonal antibody defining antigenic determinants on subpopulations of mammalian neurones and Trypanosoma cruzi parasites , 1982, Nature.

[23]  S. Gordon,et al.  Degradation of basic protein in myelin by neutral proteases secreted by stimulated macrophages: a possible mechanism of inflammatory demyelination. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[24]  R. Damian.  Molecular Mimicry: Antigen Sharing by Parasite and Host and Its Consequences , 1964, The American Naturalist.

[25]  Z. Brener.  Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. , 1962, Revista do Instituto de Medicina Tropical de Sao Paulo.

[26]  V. Nussenzweig,et al.  Structural and functional properties of Trypanosoma trans-sialidase. , 1994, Annual review of microbiology.

[27]  M. Oldstone,et al.  Molecular mimicry as a mechanism for the cause and a probe uncovering etiologic agent(s) of autoimmune disease. , 1989, Current topics in microbiology and immunology.

[28]  E. Harlow,et al.  Antibodies: A Laboratory Manual , 1988 .

[29]  Z. Brener.  Biology of Trypanosoma cruzi. , 1973, Annual review of microbiology.